A.G. Edwards

Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. The company is best known for its pioneering work in transcatheter aortic valve replacement (TAVR) technology, specifically the SAPIEN valve family. Beyond heart valves, Edwards provides advanced hemodynamic monitoring systems used in surgical and intensive care settings to improve clinical outcomes. Their portfolio focuses on minimally invasive solutions to treat complex cardiovascular conditions while reducing recovery times. Headquartered in Irvine, California, the company maintains a strong global presence and continues to expand its reach into transcatheter mitral and tricuspid valve therapies.